- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03201224
Image Transmission Applied to Organ Transplant: Before-after Study of the Effectiveness of the Device
Image Transmission Applied to Organ Transplant: Before-after Study of the Device of the Effectiveness
In the complex process of organ transplant, two of the major steps are:
- evaluation of the organs of potential donors in health institutions:
- proposing grafts to the transplant teams, according to rules defined at the national level.
In the absence of the possibility of transmitting the images between the deceased donor sites and the transplant teams, the visualization of these examinations does not take part in the decision-making of the transplant team. This leads in the displacement of the transplant team in order to verify the grafts after acceptance of the graft proposal.
The "Cristal Image" project is a visualisation project for the transplant teams, in real time, at the time of the proposal of the graft so that they can give an opinion (acceptance, refusal) in less than 20 minutes (legal delay for a vital organ) after analyzing the medical records provided and the imaging data (scanner, ultrasound (s), coronary angiography, etc.).
The hypothesis of the project is that the implementation of a secure image transmission (complete anonymisation of the data of the donor) before the acceptance by the team, will allow an optimization of the use of the qualified organs by reducing risks, unnecessary displacement of transplant surgical teams, and securing the allocation of organs to recipient patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Saint-Denis, France, 93200
- Recruiting
- Agence de la biomédecine
-
Contact:
- Hélène Logerot, MD
- Email: helene.logerot@biomedecine.fr
-
Principal Investigator:
- Hélène Logerot, MD
-
Principal Investigator:
- Huot Olivier, MD
-
Sub-Investigator:
- Laouabdia Karim, MD
-
Sub-Investigator:
- Bastien Olivier, MD, PhD
-
Sub-Investigator:
- Legeai Camille, MD
-
Sub-Investigator:
- Lucas-Samuel Samuel, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- French Donors who died in brain death, at least one organ of which was proposed for transplantation (kidneys, liver, heart, lung); Recipients transplanted during the same periods.
Exclusion Criteria:
- Donors who died after cardiac arrest
- Donors taken care in a foreign country or outside the Metropolitan France
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group without image transmission
"Before" Group
|
|
|
Group with image transmission
"After" Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of successful organ transplantation among those sampled.
Time Frame: 3 months after transplantation for kidney, 1 year after transplantation for the other organs
|
3 months after transplantation for kidney, 1 year after transplantation for the other organs
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of assigned organs but not sampled
Time Frame: Immediately after the decision of the transplant team
|
Immediately after the decision of the transplant team
|
|
Number of useless graft transportation
Time Frame: Immediately after the decision of the transplant team
|
Immediately after the decision of the transplant team
|
|
Number of useless graft team transportation
Time Frame: Immediately after the decision of the transplant team
|
Immediately after the decision of the transplant team
|
|
Mortality or function stop
Time Frame: 1 year after transplantation
|
1 year after transplantation
|
|
Duration of the graft assignment
Time Frame: Immediately after graft assignment
|
Immediately after graft assignment
|
|
Cost of sampling process
Time Frame: Immediately after the sampling process
|
Immediately after the sampling process
|
|
Use of image transmission by the graft team
Time Frame: Immediately after decision of the transplant team to accept or not the graft
|
Immediately after decision of the transplant team to accept or not the graft
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Isabelle Durand-Zaleski, MD, PhD, Assistance Publique - Hôpitaux de Paris - DRCD URC Eco
Publications and helpful links
General Publications
- Reddy MS, Bhati C, Neil D, Mirza DF, Manas DM. National Organ Retrieval Imaging System: results of the pilot study. Transpl Int. 2008 Nov;21(11):1036-44. doi: 10.1111/j.1432-2277.2008.00720.x.
- Rosenkrantz AB, Campbell N, Wehrli N, Triolo MJ, Kim S. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation. Radiology. 2015 Feb;274(2):426-33. doi: 10.1148/radiol.14140069. Epub 2014 Oct 7.
- Furlow B. Solid organ donation and transplantation. Radiol Technol. 2012 Mar-Apr;83(4):371-89. Erratum In: Radiol Technol. 2012 May-Jun;83(5):446.
- Fregeville A, De Bazelaire C, Zagdanski A, Albiter M, Desgrandchamps F, De Kerviler E. [Value of whole body CTA in the management of brain-dead patients]. J Radiol. 2010 Jan;91(1 Pt 1):37-44. doi: 10.1016/s0221-0363(10)70004-4. French.
- Charrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1.
- Zarca K, Dupont JK, Jacoud L, Bulsei J, Huot O, Logerot H, Durand-Zaleski I. Effectiveness and efficiency of teleimaging in the transplantation process: a mixed method protocol. BMC Health Serv Res. 2019 Sep 18;19(1):672. doi: 10.1186/s12913-019-4488-0.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PREPS - Cristal Images
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transplantation, Telemedicine
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania
-
Attune Health Research, Inc.Rheumatology Research FoundationRecruiting
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompleted
-
Wake Forest University Health SciencesCompleted
-
National University Health System, SingaporeCompletedTelemedicineSingapore
-
CochlearCompletedTelemedicineUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
Buzzi Children's HospitalCompleted
Clinical Trials on "After" Group
-
Karadeniz Technical UniversityCompleted
-
Hospital de Clinicas de Porto AlegreCompleted
-
West China HospitalUnknownStomach Neoplasms | Esophageal NeoplasmsChina
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustCompletedAcute Coronary SyndromeUnited Kingdom
-
Funda Kardas OzdemirCompletedStress | ComfortTurkey (Türkiye)
-
US Department of Veterans AffairsWithdrawn
-
University of Colorado, DenverCompletedCardiovascular Diseases | Diabetes | Preterm Birth | Overweight and Obesity | Preeclampsia | Gestational Diabetes | Small for Gestational Age at Delivery | Gestational HypertensionUnited States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalUnknownExternal Causes of Morbidity and Mortality | Complications; Cesarean Section | Failure of Cervical Dilatation | Wound Infection,Turkey
-
Craig HospitalUniversity of Michigan; Kessler FoundationActive, not recruitingSpinal Cord InjuriesUnited States